Ranbaxy May Negotiate on Congolese Drug Sales
Leading Indian generics producer Ranbaxy is understood to be negotiating
a drug supply deal with the Democratic Republic of Congo (DRC). Although the
company has refused to comment, an Indian industry group has quoted the DRC
foreign minister during a visit to the country. The minister apparently claimed
that the order would be large enough to meet the DRC's domestic demand "at
reasonably concessional prices."
Such a claim would imply a substantial deal, assuming the country's government
is able to fund any agreement adequately. It is currently unclear which drugs
the DRC's authorities would seek to source from Ranbaxy's diverse product portfolio,
although the Indian drugmaker has recently received tentative US FDA and WHO
approval for three of its antiretroviral products under the PEPFAR HIV/AIDS
initiative's expedited review process.
Upcoming Events
-
18Jul
-
21Oct